The University of Vermont Medical Center is a five-campus academic medical facility under the corporate umbrella of The University of Vermont Health Network corporate that is anchored by a 562-bed hospital. UVM is located in Burlington, Vermont, and serves as both a regional referral center and a community hospital.

There are 562 beds in Fletcher Allen Health Care (FAHC), General Clinical Research Center (GCRC).

During the past decade, Fletcher Allen Health Care (FAHC), General Clinical Research Center (GCRC) conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fletcher Allen Health Care (FAHC), General Clinical Research Center (GCRC)" #1 collaborator was "Johns Hopkins Bloomberg School of Public Health" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Fletcher Allen Health Care (FAHC), General Clinical Research Center (GCRC)" are "Dengue" (3 trials) and "Dengue Virus" (1 trials). Many other conditions were trialed in "Fletcher Allen Health Care (FAHC), General Clinical Research Center (GCRC)" in a lesser frequency.

Most popular intervention types in "Fletcher Allen Health Care (FAHC), General Clinical Research Center (GCRC)" are "Biological" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "TetraVax-DV Vaccine - Admixture TV003" (2 trials), "TetraVax-DV Vaccine - Admixture TV005" (2 trials), "Investigational Vaccine for DEN1" (1 trials) and "Placebo injection" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fletcher Allen Health Care (FAHC), General Clinical Research Center (GCRC)" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Fletcher Allen Health Care (FAHC), General Clinical Research Center (GCRC)". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Fletcher Allen Health Care (FAHC), General Clinical Research Center (GCRC), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Fletcher Allen Health Care (FAHC), General Clinical Research Center (GCRC), 4 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".